LONDON, Feb. 19 -- The government of the United Kingdom issued the following news:
We are making changes to the Veterinary Medicines Digital Service (VMDS) to improve the marketing authorisation application process.
What's changing
From 27 February 2026, applicants submitting generic, hybrid or informed consent marketing authorisation applications will only be able to select valid, authorised reference products within VMDS.
This change will:
* prevent incorrect or outdated reference product choices
* improve the quality of information submitted
* Remove an unnecessary delay at the validation stage
The new functionality will go live at the beginning of March 2026.
Guidance video
Watch our short video explaining the updated reference product selection process in VMDS:https://youtu.be/HuyL8O2cFfs
Get help
If you experience any issues with this feature, report them using the online technical service desk within VMDS.
Disclaimer: Curated by HT Syndication.
